Multicenter phase II trial of temozolomide in patients with glioblastoma multiforme at first relapse

Brada, M., Hoang-Xuan, K., Rampling, R., Dietrich, P.-Y., Dirix, L.Y., Macdonald, D., Heimans, J.J., Zonnenberg, B.A., Bravo-Marques, J.M., Henriksson, R., Stupp, R., Yue, N., Bruner, J., Dugan, M., Rao, S., Zaknoen, S.·2001·Annals of Oncology
DOI 10.1023/a:1008382516636

Cited by (372)

Items 301–372 of 372

  1. Novel therapeutics in adult malignant brain gliomas
    Michele Reni, Elena A. Mazza, Alicia Tosoni, Alba Ariela Brandes · 2005 · Expert Opinion on Investigational Drugs
  2. Chimiothérapie et traitements ciblés des glioblastomes
    Olivier Louis Chinot, P. Soulier, Marc Frénay · 2010 · Neurochirurgie
  3. Carboplatin and oral cyclophosphamide combination after temozolomide failure in malignant gliomas
    Emel Yaman, Süleyman Buyukberber, Aytuğ Üner, Uğur Çoşkun, Deniz Yamaç, Banu Öztürk, Ali Osman KAYA, Ramazan Yıldız · 2008 · Tumori Journal
  4. Pretreatment inflammatory indices predict Bevacizumab response in recurrent Glioma
    Alicia Martínez‐González, Raquel Cabrera, Marta Lloret, Pedro C. Lara · 2020 · Cancer Drug Resistance
  5. Temozolomide for malignant gliomas in British Columbia: A population-based cost-effectiveness analysis
    ED Greanya, SCM Taylor, F Hu BscPharm, Jeff Barnett, Brian Arthur Thiessen · 2004 · Journal of Oncology Pharmacy Practice
  6. Supportive Care in Patients Using Tumor Treating Fields Therapy
    Mario E. Lacouture, John DeNigris, Andrew A. Kanner · 2016 · Springer eBooks
  7. Trends in Efficacy Endpoints in Phase II Glioblastoma Trials: A Regulatory Science Analysis (FY2020–FY2022)
    Shinya Watanabe, Makoto Maeda, Narushi Sugii, Masanobu Yamada, Yoshihiro Arakawa, Kimika Nakamura, Koichi Hashimoto, Eiichi Ishikawa · 2025 · Cancers
  8. Combination Cancer Therapy and Reference Models for Assessing Drug Synergy in Glioblastoma
    Semyon Sinyavskiy, Nelly S. Chmelyuk, Daria Yu. Travnikova, Vsevolod Vadimovich Belousov, Tatiana O. Abakumova · 2025 · Current Oncology
  9. XPO1-inhibitor Selinexor induces MGMT expression by activating PKA-CREB signaling in IDH wildtype glioblastoma
    Josephine A. Mapunda, Yuta Suzuki, Danielle M. Burgenske, Paul A. Decker, Lin Zhang, Jeanette E. Eckel‐Passow, Jann Nagina Sarkaria, Gaspar J. Kitange · 2025 · Frontiers in Oncology
  10. Quality of life in glioblastoma after the introduction of temozolomide: a systematic review
    Thales Augusto Oliveira Dias, Dyecika Souza Couto, Edvaldo José Rodrigues Cardoso · 2022 · Research Society and Development
  11. Long-term daily temozolomide with dose-dependent efficacy in MGMT promotor methylation negative recurrent high-grade astrocytoma
    Zhengqiu Zhou, Tracy A. Howard, John Lee Villano · 2017 · Cancer Chemotherapy and Pharmacology
  12. End points for Phase II trials in recurrent glioblastoma: the cornerstone for a new era
    Enrico Franceschi, Raffaele Agati, Alba Ariela Brandes · 2011 · Expert Review of Anticancer Therapy
  13. Application of Decision-Analytic Modelling in Health Economic Evaluations
    Janne A. Martikainen · 2008
  14. Salvage chemotherapy with procarbazine and fotemustine combination in the treatment of temozolomide treated recurrent glioblastoma patients
    Antonio Silvani, E. Lamperti, Paola Gaviani, Marica Eoli, Anna Fiumani, Andrea Salmaggi, Chiara Falcone, Graziella Filippini, A. Botturi, Amerigo Boiardi · 2008 · Journal of Neuro-Oncology
  15. The dendritic therapy with its potential applications in pancreatic cancer.
    Stefaan Van Gool · 2009 · PubMed
  16. Radiotherapy with Concurrent and Adjuvant Temozolomide: A New Standard of Care for Glioblastoma Multiforme
    Warren P. Mason, R.O. Mirimanoff, Roger Stupp · 2006 · Progress in Neurotherapeutics and Neuropsychopharmacology
  17. Clinical Update: Treatment of Glioblastoma Multiforme with Radiolabeled Antibodies that Target Tumor Necrosis
    Randy L. Jensen, Joseph S. Shan, Bruce D. Freimark, Debra Harris, Steven King, Jennifer C. Lai, Missag Hagop Parseghian · 2010 · Current Cancer Therapy Reviews
  18. Long-term survival with unmethylated MGMT glioblastoma multiforme
    Joana Savva-Bordalo, André Soares, Patrícia Rocha, Manuel Jácome, Joaquina Maurício, Rui Ferreira · 2011 · International Journal of Case Reports and Images
  19. ENHANCED p53-DEPENDENT GROWTH INHIBITION OF HUMAN GLIOBLASTOMA CELLS BY COMBINATORIAL TREATMENT OF TEMOZOLOMIDE AND NOVEL PURIFIED NATURAL CARBOHYDRATE OF PLEUROTUS FLORIDA
    Priyankar Maji, Ranodeep Chatterjee, Biswa Choudhury, Urmi Chatterji, Jhuma Ganguly · 2017 · International Journal of Pharmacy and Pharmaceutical Sciences
  20. Switch to generic formulation of temozolomide results in statistically significant increase in grade 3 and 4 bone marrow toxicity in glioma patients in the province of Alberta
    Egiroh Omene, Omar Mohammed Abdel-Rahman, Eugene Batuyong, Samir Patel, Roland Coppens, Jacob C. Easaw, Kelvin Young · 2023 · Neuro-Oncology Practice
  21. Positron Emission Tomography Measurement of Drug Kinetics
    Azeem Saleem, Pat Price · 2007 · Humana Press eBooks
  22. Long-lasting partial regression of glioblastoma multiforme achieved by edotecarin: case report.
    Eduard Vrdoljak, Marijo Boban, Žana Saratlija-Novaković, Josipa Jović · 2006 · PubMed Central
  23. Avances en el tratamiento del glioblastoma multiforme
    Sonia Jaramillo, Walter Osorio-Cardona, Juan Carlos Espitia · 2010 · Universitas Médica
  24. Contribution of Ectodomain Mutations in Epidermal Growth Factor Receptor to Signaling in Glioblastoma Multiforme
    Marta L. Rojas · 2011 · Digital Commons-TMC (Texas Medical Center)
  25. Temozolomide treatment in glioma Experiences in two university hospitals in finland
    Hanna O Mäenpää, Kirsimari Aaltonen, Riitta Mäntylä, Heikki R. I. Minn · 2004 · Acta Oncologica
  26. Anti-Angiogenic Therapy for Malignant Glioma: Insights and Future Directions
    Paula Province, Xiaosi Han, Lindsay Burt, Muhammad Hassan · 2011 · InTech eBooks
  27. Radiotherapy with concurrent and adjuvant temozolomide: a new standard of care for glioblastoma multiforme
    Warren P. Mason, R.O. Mirimanoff, Roger Stupp · 2006 · Cambridge University Press eBooks
  28. Comprehensive Brain Tumor Management
    Mandeep S. Tamber, Mark Bernstein · 2009 · Springer eBooks
  29. Treatment of High-Grade Gliomas in Adults
    Jan Drappatz, Andrew David Norden, Patrick Yung Wen · 2009 · Springer eBooks
  30. The outcomes of concomitant radiation plus temozolomide followed by adjuvant temozolomide for newly diagnosed high grade gliomas: the preliminary results of single center prospective study.
    Hanan Shawky, Abo Hamar Ah, Samar Galal, Fatma Zakaria, D El-Shorbagy · 2009 · PubMed
  31. Glioblastoma: Temozolomide-Based Chemotherapy
    Dagmar Beier, Christoph Patrick Beier · 2010 · Springer eBooks
  32. Brain Tumors, Intraocular and Orbital Tumors
    Paul Chumas, Susan V. Picton, Ian Simmons, Manoj Parulekar · 2016 · Springer eBooks
  33. Supratentorial High-Grade Gliomas
    Rene O. Sanchez-Mejia, Anu Banerjee, Nalin M. Gupta · 2006 · Springer eBooks
  34. Compliance of temozolamide with concurrent radiotherapy as an adjuvant in patients with high grade glioma – a retrospective study
    V. Arun Ramanan, S. Jeeva, K. R. Sowmiya · 2023 · European Journal of Clinical and Experimental Medicine
  35. TEMOZOLOMIDE IN MALIGNANT ASTROCYTIC GLIOMAS
    K. E. Borisov, D. D. Sakayeva · 2012 · Russian Journal of Oncology
  36. Malignant Glioma: Viewpoint—Chemotherapy
    Roger Stupp, Krisztián Homicskó, John Gregory Cairncross · 2015 · Springer eBooks
  37. The microbiota in human glioma and its association with immune microenvironment
    Yihui Wang, Qiaoxing Liang, Hongrong Hu, Bo Li, Qing fan Yang, Lai Wei, Cong Li, JiangHuang WANG · 2020 · Scientia Sinica Vitae
  38. Protein Tyrosine Phosphatase Receptor Type Kappa Is A Glioma Tumor Suppressor That Predicts Survival And Response To Therapy
    Supreet Agarwal · 2013
  39. Efficacy of Unapproved Drug Temozolomide in Patients with Recurrent Malignant Glioma
    Yumiko Goto, Kazuhiro Ishikawa, Mikiyo Maeda, Yasukazu Kajita, Toshihiko Wakabayashi, Jun Yoshida, Toshitaka Nabeshima · 2005 · Iryo Yakugaku (Japanese Journal of Pharmaceutical Health Care and Sciences)
  40. Brain tumors
    Jeanette K. Pueschel, Lynn Stuart Ashby, William R. Shapiro · 2003 · Cancer chemotherapy and biological response modifiers
  41. Studies on viral gene transfer and angiogenesis inhibition in experimental glioma models
    Peter Csaba Huszthy · 2006 · NORA - Norwegian Open Research Archives
  42. Nuevos quimioterápicos en Neurooncología
    Carmen Balañá, Rafael Rosell, R. Ballester Alabau, Antonio Arellano, Beatriz Cirauqui, Teresa Morán · 2003 · Revista de Oncología
  43. Avaliação da resposta celular mediada pelo quimioterápico temozolomida associada ao inibidor do reparo do DNA metoxiamina em linhagens de glioblastoma.
    Ana Paula de Lima Montaldi · 2009 · Digital Library of Theses and Dissertations (Universidade de São Paulo)
  44. Glioblastoma: Anti-tumor Action of Cyclosporin A and Functionally Related Drugs
    Bozena Kaminska, Magdalena Ewa Tyburczy, Konrad R. Gabrusiewicz, Małgorzata Sielska · 2011 · Springer eBooks
  45. Combined chemotherapy and immunotherapy against experimental malignant brain tumors
    Sara Fritzell · 2013 · Lund University Publications (Lund University)
  46. Dependence of CT attenuation values on scanner type using in vivo measurements
    Mithun N. Prasad, Alicia Meza, Hyun J. Kim, Matthew S. Brown, Fereidoun G. Abtin, Jonathan Gerald Goldin, Michael F. McNitt‐Gray · 2008 · Proceedings of SPIE, the International Society for Optical Engineering/Proceedings of SPIE
  47. Improved delivery of molecularly targeted agents upon modulation of multidrug resistance efflux proteins at mouse blood brain barrier
    Mukul Minocha · 2012 · MOspace Institutional Repository (University of Missouri)
  48. RADIOSENSITIVITY ENHANCEMENT OF HUMAN GLIOBLASTOMA MULTIFORME BY A HERPES SIMPLEX VIRUS VECTOR
    Constantinos G. Hadjipanayis · 2005 · D-Scholarship@Pitt (University of Pittsburgh)
  49. Recent advances in the medical therapy of high-grade gliomas
    Warren P. Mason, Roger Stupp · 2006 · Future Neurology
  50. Poly(ADP-ribose) polymerase inhibition and its potential use in malignant melanoma
    Ruth Plummer · 2006 · Expert Review of Dermatology
  51. Temozolomide in the treatment of malignant brain tumors in children
    Elżbieta Korab-Chrzanowska, Stanisław Kwiatkowski · 2003 · Jagiellonian University Repository (Jagiellonian University)
  52. Opciones terapéuticas del astrocitoma de bajo grado supratentorial en el adulto
    Ricardo Prat-Acín, Inmaculada Galeano Senabre · 2008 · Archivos de Neurociencias
  53. Antiangiogenic therapies for malignant gliomas: new markers for targeted treatment
    Andrea Biondi, Gaetano Finocchiaro, Lucia Cuppini · 2012
  54. Manejo de los tumores hipofisarios agresivos
    Javier Aller, Mariana Campderá Michelena, Nuria Palacios García, Javier Estrada García · 2014 · Elsevier eBooks
  55. Chemoradiotherapy: Radiation Total Dose and Fractionation
    Silvia Chiesa, Mario Balducci, Milena Ferro, A.R. Alitto, Vincenzo Valentini · 2016 · Current clinical pathology
  56. Dendritic cell-based tumor vaccination for high-grade gliomas
    Hilko Ardon · 2011
  57. Brain Gliomas in the Elderly
    Cristina Izquierdo, François Ducray · 2017 · Springer eBooks
  58. Temozolomide during and after radiation therapy for WHO grade III gliomas: preliminary report of a prospective multicenter study Young-Hoon KimChul-Kee ParkWon Ho ChoIn Ah KimSeyoung Moon • Gheeyoung ChoeSung-Hye ParkIl Han KimDong Gyu Kim •
    Hee-Won JungMin · 2011
  59. Extendierte adjuvante Chemotherapie mit Temozolomid in der Behandlung maligner Gliome - Eine retrospektive Datenanalyse zur Wirksamkeit und Hämatotoxizität im klinischen Alltag
    Julia Karges · 2018
  60. The role of receptor tyrosine kinases in mediating glioblastoma resistance to radiotherapy and temozolomide
    Zammam Areeb · 2020 · Minerva Access (University of Melbourne)
  61. Immunotherapy for glioblastoma as a means to overcome resistance to standard therapy
    Kristen A. Batich, John Howard Sampson, Mustafa Khasraw, Henry S. Friedman, David M. Ashley · 2021 · Elsevier eBooks
  62. Sensitivity to and functional effects of tricyclic agents on glioma: an immunohistochemical and in vitro study
    Katharine Peregrin · 2011 · UPT. Syiah Kuala University Library (Syiah Kuala University)
  63. Brain Tumors, Intraocular and Orbital Tumors
    Paul Chumas, Susan V. Picton, Harry Willshaw · 2008 · Springer eBooks
  64. Cytostatic and cytotoxic drugs
    Ami Sabharwal, Mark Ross Middleton · 2010 · Side effects of drugs annual
  65. Brain tumors
    CORRIE J. STAYNER, RACHEL M. LOPEZ, KARLA M. TUZZOLINO · 2013 · Elsevier eBooks
  66. Modern advances in molecular and cellular biology in the treatment of glioblastoma
    Ivan Andreevich Stepanov, В. А. Сороковиков, В. А. Белобородов, А. Л. Кривошапкин, A. S. Gaitan, M.A. Shameeva · 2022 · P A Herzen Journal of Oncology
  67. Retrospective Analysis of the Factors Affecting Recurrence, Survival, and Effect of Hippocampus Radiotherapy Doses on Neurocognitive Functions in Patients Diagnosed with Glioblastoma Multiforme
    S Inan, Öznur Dönmez Tutanç, Hülya Ertaş, Fatih Aydemir, Burcu Caner, Turgay Toksoy, Pınar Çona · 2024 · Gazi Medical Journal
  68. Estudo de marcadores de diagnóstico e prognóstico em gliomas
    Ana Filipa Guedes · 2010 · Portuguese National Funding Agency for Science, Research and Technology (RCAAP Project by FCT)
  69. Chemotherapy of high-grade astrocytomas: temozolomide
    Kester A. Phillips, David Schiff · 2026 · Elsevier eBooks
  70. Potentialisation des chimiothérapies dans le traitement du glioblastome : étude des transporteurs ABC et ouverture de la barrière hémato-encéphalique par ultrasons
    Antonin Dréan · 2018 · theses.fr (ABES)
  71. BUDS: Benchmark Uncertainty Design Selection for two-stage single-arm phase II trials
    Rebecca T. Irlmeier, Zhuoli Jin, Fei Ye · 2026 · BMC Medical Research Methodology
  72. Malignant Glioma: Chemotherapy Perspective
    Roger Stupp, John Gregory Cairncross · 2008 · Springer eBooks